AROMATASE-ACTIVITY, SERUM ESTRADIOL AND THEIR CORRELATION WITH DEMOGRAPHIC INDEXES

被引:7
作者
JACOBS, S
MACNEILL, F
LONNING, P
DOWSETT, M
JONES, A
POWLES, T
机构
[1] ROYAL MARSDEN HOSP, DEPT MED, LONDON, ENGLAND
[2] ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
[3] HAUKELAND HOSP, DEPT ONCOL & RADIOPHYS, N-5016 BERGEN, NORWAY
关键词
D O I
10.1016/0960-0760(92)90421-E
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peripheral aromatase activity was measured in 24 postmenopausal women suffering from advanced breast cancer. The % conversion of androstenedione to oestrone was then assessed for a significant correlation with age, weight, height, Quetelets index (weight/height2, Q.I.) and length of menopause. Serum oestradiol (E2) levels were measured in 22 of the subjects and compared with the same indices. There was no correlation between E2 or aromatase activity with the length of menopause (P = 0.3 and P = 0.5, respectively). In our data aromatase activity did not correlate with age (P > 0.5, n = 22). Serum E2 levels (P = 0.07, n = 20) expressed a negative correlation (i.e. decreased) with age. There was also a poor correlation between aromatase activity and weight of Quetelets index (P = 0.3, n = 20 for both). Serum E2 levels showed a statistically significant correlation with weight (P = 0.01, n = 21), but the relationship with Quetelets index just failed to attain statistical significance (P = 0.07, n = 20). In both cases the regression line was positive. When aromatase activity was correlated with serum E2 levels the regression line was positive but not statistically significant (P = 0.4, n = 22). The data indicate that aromatase activity is only one factor determining the differences in serum E2 levels between postmenopausal women.
引用
收藏
页码:769 / 771
页数:3
相关论文
共 11 条
  • [1] INFLUENCE OF HEIGHT, WEIGHT AND OBESITY ON RISK OF BREAST-CANCER IN AN UNSELECTED SWEDISH POPULATION
    ADAMI, HO
    RIMSTEN, A
    STENKVIST, B
    VEGELIUS, J
    [J]. BRITISH JOURNAL OF CANCER, 1977, 36 (06) : 787 - 792
  • [2] De Waard F, 1977, Cancer, V40, P1269, DOI 10.1002/1097-0142(197709)40:3<1269::AID-CNCR2820400341>3.0.CO
  • [3] 2-S
  • [4] DOWSETT M, 1987, CANCER RES, V47, P1957
  • [5] SOURCE OF ESTROGEN PRODUCTION IN POSTMENOPAUSAL WOMEN
    GRODIN, JM
    SIITERI, PK
    MACDONALD, PC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1973, 36 (02) : 207 - 214
  • [6] AMINOGLUTETHIMIDE DOSE AND HORMONE SUPPRESSION IN ADVANCED BREAST-CANCER
    HARRIS, AL
    DOWSETT, M
    JEFFCOATE, SL
    SMITH, IE
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (04): : 493 - 498
  • [7] Jacobs S, 1991, J Enzyme Inhib, V4, P315, DOI 10.3109/14756369109030396
  • [8] THE INFLUENCE OF CGS-16949A ON PERIPHERAL AROMATIZATION IN BREAST-CANCER PATIENTS
    LONNING, PE
    JACOBS, S
    JONES, A
    HAYNES, B
    POWLES, T
    DOWSETT, M
    [J]. BRITISH JOURNAL OF CANCER, 1991, 63 (05) : 789 - 793
  • [9] EFFECT OF OBESITY ON CONVERSION OF PLASMA ANDROSTENEDIONE TO ESTRONE IN POST-MENOPAUSAL WOMEN WITH AND WITHOUT ENDOMETRIAL CANCER
    MACDONALD, PC
    EDMAN, CD
    HEMSELL, DL
    PORTER, JC
    SIITERI, PK
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1978, 130 (04) : 448 - 455
  • [10] ROSE DP, 1986, CANCER SURV, V5, P671